
Trump Signs Order to Fast-Track Psychedelic Drug Reviews with $50M Funding
President Donald Trump signed an executive order to fast-track FDA review and increase federal research funding for psychedelic drugs, including ibogaine, aiming to expand treatment options for mental health disorders and veterans' PTSD while highlighting the need for careful clinical trials and regulatory oversight.
6 months ago























